BIOMAT Database Logo BIOMAT Database Logo

Appetite suppressants for obesity. 1997

B Budenholzer

UI MeSH Term Description Entries
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D010645 Phentermine A central nervous system stimulant and sympathomimetic with actions and uses similar to those of DEXTROAMPHETAMINE. It has been used most frequently in the treatment of obesity. Adipex-P,Duromine,Ionamine,Phentermine Hydrochloride,Adipex P,AdipexP,Hydrochloride, Phentermine
D005277 Fenfluramine A centrally active drug that apparently both blocks serotonin uptake and provokes transport-mediated serotonin release. Fintepla,Fenfluramine Hydrochloride,Fenfluramine Hydrochloride, (+-)-Isomer,Fenfluramine Hydrochloride, R-Isomer,Fenfluramine, (+-)-Isomer,Fenfluramine, R-Isomer,Isomeride,Pondimin,Fenfluramine Hydrochloride, R Isomer,Fenfluramine, R Isomer,Hydrochloride, Fenfluramine
D006304 Health Status The level of health of the individual, group, or population as subjectively assessed by the individual or by more objective measures. General Health,General Health Level,General Health Status,Level of Health,Overall Health,Overall Health Status,General Health Levels,Health Level,Health Level, General,Health Levels,Health Status, General,Health Status, Overall,Health, General,Health, Overall,Level, General Health,Levels, General Health,Status, General Health,Status, Health,Status, Overall Health
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001067 Appetite Depressants Agents that are used to suppress appetite. Anorectic,Anorectic Agent,Anorectics,Anorexic Drug,Anorexigenic Drug,Appetite Depressant,Appetite Suppressant,Appetite Suppressants,Appetite-Depressing Drug,Appetite-Suppressant Drug,Anorectic Agents,Anorexic Drugs,Anorexigenic Drugs,Appetite-Depressing Drugs,Appetite-Suppressant Drugs,Agent, Anorectic,Agents, Anorectic,Appetite Depressing Drug,Appetite Depressing Drugs,Appetite Suppressant Drug,Appetite Suppressant Drugs,Depressant, Appetite,Depressants, Appetite,Drug, Anorexic,Drug, Anorexigenic,Drug, Appetite-Depressing,Drug, Appetite-Suppressant,Drugs, Anorexic,Drugs, Anorexigenic,Drugs, Appetite-Depressing,Drugs, Appetite-Suppressant,Suppressant, Appetite,Suppressants, Appetite

Related Publications

B Budenholzer
Appetite suppressants as adjuncts in the treatment of obesity.
March 1996, The Journal of family practice,
B Budenholzer
Appetite suppressants reassessed.
April 1982, Drug and therapeutics bulletin,
B Budenholzer
Nonprescription appetite suppressants.
September 1983, North Carolina medical journal,
B Budenholzer
[Anti-obesity drugs--mechanism and medical indication of appetite suppressants].
March 2001, Nihon rinsho. Japanese journal of clinical medicine,
B Budenholzer
Evaluation of appetite suppressants.
December 1959, Annals of internal medicine,
B Budenholzer
Two new appetite suppressants.
June 1974, The Medical letter on drugs and therapeutics,
B Budenholzer
Appetite suppressants in pregnancy.
January 2012, Neuro endocrinology letters,
B Budenholzer
Appetite suppressants. A review.
June 1992, Drugs,
B Budenholzer
Drug Insight: appetite suppressants.
February 2005, Nature clinical practice. Gastroenterology & hepatology,
B Budenholzer
The long-term control of obesity using sustained release appetite suppressants.
June 1962, The British journal of clinical practice,
Copied contents to your clipboard!